Page 2 - Pharmaceutical Formulation News Today

KNOXVILLE, TN, January 10, 2022 ( ) – Provectus (OTCQB: PVCT) today announced that preclinical research on a formulation of the Company’s pharmaceutical-grade rose bengal against Gram-positive (G+) bacteria was published in Molecules, an open-access journal of chemistry.

/PRNewswire/ -- The Pharmaceutical Formulation market will register an incremental spend of about USD 183 Billion, growing at a CAGR of 6.23% during the...

/PRNewswire/ -- The Pharmaceutical Formulation market will register an incremental spend of about USD 183 Billion, growing at a CAGR of 6.23% during the...

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

/PRNewswire/ -- The Pharmaceutical Formulation market is growing at a CAGR of 6.23% during the five-year forecast period. A targeted strategic approach to...

EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion 05-May-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Grant of European patent entitled Pharmaceutical Formulation for Use in Spinal Fusion Schlieren (Zurich), Switzerland, May 5, 2021 -...

EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Patent Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion 05-May-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this anno...

About Fibrin-PTH (KUR-113) Fibrin-PTH (KUR-113) consists of a natural fibrin-based healing matrix with an immobilized targeted bone growth factor (truncated human parathyroid hormone (PTH) analog). Fibrin-PTH (KUR-113) is designed to be applied directly into and around an intervertebral body fusion device as a gel, where it polymerizes in situ. Fibrin-PTH (KUR-113) functions via the well-established mechanism of action of parathyroid hormone; has been demonstrated in animal models of spinal fus...